- Ramsay Health’s net income significantly declined by 97% year-over-year, from A$888.7 million to A$24.0 million.
- The final dividend per share remained steady at A$0.40, unchanged from the previous year.
- Total revenues and other income rose by 6.3% compared to the previous year, reaching A$17.84 billion.
- Earnings before interest and taxes (EBIT) from continuing operations decreased by 29% year-over-year, totaling A$706.2 million.
- Earnings before interest, taxes, depreciation, and amortization (EBITDA) from continuing operations showed a slight increase of 1.6%, totaling A$2.16 billion.
- Investment analysts provided the following ratings: 2 buys, 14 holds, and 1 sell.
A look at Ramsay Health Care Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 2 | |
| Growth | 2 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on Smartkarma’s Smart Scores, Ramsay Health Care shows a positive long-term outlook. With a strong momentum score of 4, indicating good market performance, investors can expect continued growth and profitability. While the company’s value score is at a solid 3, suggesting a reasonably priced stock, its dividend and growth scores both stand at 2. This indicates moderate potential for dividend payouts and growth in the future. Ramsay Health Care‘s resilience score at 3 highlights its ability to navigate challenges and maintain stability in the healthcare sector.
Ramsay Health Care Ltd. provides essential health care services, specializing in private hospital services such as rehabilitation, psychiatric care, and complex surgeries. Operating across Australia, Indonesia, and Europe, the company owns and manages a network of health care facilities. With a promising momentum score and a solid foundation in providing critical healthcare services, Ramsay Health Care appears well-positioned for long-term success.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
